Pantoprazole effectively controls intra-oesophageal pH and promotes oesophageal healing: Further evidence for ranitidine-induced tolerance in patients with gastro-oesophageal reflux disease

Clinical Drug Investigation

Volumn 21, Issue 4, 2001, Pages 265-272

  Awad, R A ^a   Camacho, S ^a   Dibildox, M ^a  

^a HOSPITAL GENERAL DE MÉXICO   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

PANTOPRAZOLE; RANITIDINE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERANCE; ENDOSCOPY; ESOPHAGUS PH; FEMALE; GASTROESOPHAGEAL REFLUX; HUMAN; MAJOR CLINICAL STUDY; MALE; PH MEASUREMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; STATISTICAL ANALYSIS; TACHYPHYLAXIS;

EID: 0035050137     PISSN: 11732563     EISSN: None     Source Type: Journal    
DOI: 10.2165/00044011-200121040-00004     Document Type: Article

References (32)

1. Costs of acid-related disorders to a health maintenance organization
2. Quality of life and cost of therapy in reflux disease
3. Appropriate acid suppression for optimal healing of duodenal ulcer and gastro-oesophageal reflux disease
4. Do we know the cause of reflux disease?
5. Gastroesophageal reflux disease
6. Appropriate acid suppression for the management of gastro-oesophageal reflux disease
7. Ambulatory 24-h esophageal pH monitoring: Normal values, optimal thresholds, specificity, sensitivity, and reproducibility
8. The relationship between the control of pH and healing and symptom relief in gastro-oesophageal reflux disease
9. Speed of healing and symptom relief in grade II to IV gastroesophageal reflux disease: A meta-analysis
10. Pantoprazole: A new proton pump inhibitor in the management of upper gastrointestinal disease
11. The esophagus. Handbook and atlas of endosopy
12. Clinical superiority of pantoprazole over ranitidine in the treatment of reflux esophagitis grade II and III. A prospective, double-blind, double-placebo study. Mexican clinical experience
13. 2-receptor antagonists. An overview
14. 2-receptor antagonists in the treatment of gastro-oesophageal reflux disease
15. Optimizing acid suppression for treatment of acid-related diseases
16. Development of the 24-hour intraesophageal pH monitoring composite scoring system
17. Evidence for the efficacy of a 28-day long term therapy of pantoprazole over ranitidine in reflux esophagitis. A 24 hour ambulatory combined pH and manometry study
18. Prolonged intraesophageal pH monitoring with 16-hr overnight recording. Comparison with '24-hr' analysis
19. Meta-analyses of cisapride, omeprazole and ranitidine in the treatment of GORD: Implications for treating patient subgroups
20. Twenty-four-hour intragastric pH: Tolerance within 5 days of continuous ranitidine administration
21. Pharmacodynamic modeling of the acid inhibitory effect of ranitidine in patients in an intensive care unit during prolonged dosing: Characterization of tolerance
22. 2-receptor antagonists: Intragastric acidity in patients with duodenal ulcer
23. Tolerance during 29 days of conventional dosing with cimetidine, nizatidine, famotidine or ranitidine
24. Gastro-oesophageal reflux during 3 months of therapy with ranitidine in reflux oesophagitis
25. Review article: The pharmacological inhibition of gastric acid secretion - Tolerance and rebound
26. Reliable acid suppression with pantoprazole contrasts with rapid development of tolerance to ranitidine in healthy individuals
27. Efficacy and tolerability of pantoprazole versus rantidine and famotidine in patients with gastro-oesophageal reflux disease: Multicentre, open, randomised, controlled studies
28. Comparative trial of pantoprazole and ranitidine in the treatment of reflux esophagitis. Results of a German multicenter study
29. Pantoprazole 20 mg is effective for relief of symptoms and healing of lesions in mild reflux oesophagitis
30. Efficacy and tolerability of 20 mg pantoprazole versus 300 mg ranitidine in patients with mild reflux-oesophagitis: A randomized, double-blind, parallel, and multicentre study
31. Low-dose pantoprazole (20mg) is effective for treatment of mild reflux oesophagitis
32. Treatment of reflux oesophagitis of moderate and severe grade with ranitidine or pantoprazole - Comparison of 24 hour intragastric and oesophageal pH